Alignment Healthcare (ALHC) Stock Forecast, Price & News

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alignment Healthcare in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ALHC shares.
View ALHC analyst ratings or view top-rated stocks.

6 brokers have issued 12-month price targets for Alignment Healthcare's shares. Their ALHC share price forecasts range from $8.00 to $12.00. On average, they expect the company's share price to reach $10.63 in the next twelve months. This suggests a possible upside of 61.0% from the stock's current price.
View analysts price targets for ALHC or view top-rated stocks among Wall Street analysts.

Alignment Healthcare's stock was trading at $11.76 at the beginning of 2023. Since then, ALHC shares have decreased by 43.9% and is now trading at $6.60.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our ALHC earnings forecast.

Alignment Healthcare, Inc. (NASDAQ:ALHC) announced its quarterly earnings data on Thursday, August, 3rd. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.06. The business had revenue of $462.38 million for the quarter, compared to analysts' expectations of $436.88 million. Alignment Healthcare had a negative net margin of 10.03% and a negative trailing twelve-month return on equity of 68.85%.

Alignment Healthcare updated its third quarter 2023 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $440.00 million-$445.00 million, compared to the consensus revenue estimate of $428.29 million.

(ALHC) raised $490 million in an initial public offering on Friday, March 26th 2021. The company issued 27,200,000 shares at $17.00-$19.00 per share. Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and UBS Investment Bank, Piper Sandler and Raymond James were co-managers.

Alignment Healthcare trades on the NASDAQ under the ticker symbol "ALHC."

Alignment Healthcare's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (3.45%), Brown Advisory Inc. (2.01%), State Street Corp (1.08%), Geode Capital Management LLC (0.94%), William Blair Investment Management LLC (0.73%) and Renaissance Technologies LLC (0.55%). Insiders that own company stock include Atlantic (Aln Hlth) L General, Christopher J Joyce, Dawn Christine Maroney, Dinesh M Kumar, Donald Steven Furman, Jeffrey H Margolis, John E Kao, Joseph S Konowiecki, Michael Curtis Foster, Richard A Cross, Robert Thomas Freeman, Warburg Pincus Llc and Warburg Pincus Partners Gp Llc.
View institutional ownership trends.

Shares of ALHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALHC stock can currently be purchased for approximately $6.60.

Alignment Healthcare (NASDAQ:ALHC) has a market capitalization of $1.24 billion and generates $1.43 billion in revenue each year. The company earns $-149,550,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis.

The company employs 1,037 workers across the globe.

Alignment Healthcare's mailing address is 1100 W. TOWN AND COUNTRY ROAD SUITE 1600, ORANGE CA, 92868. The official website for the company is www.alignmenthealthcare.com. The company can be reached via phone at 844-310-2247 or via email at alignmentir@westwicke.com.